Leslie Patmore
Directeur/Membre du Conseil chez Safety Pharmacology Society
Profil
Leslie Patmore is currently the Managing Director at Aptuit Consulting, Inc. and the Director at Safety Pharmacology Society.
Previously, Patmore worked as the Director-Pharmacology & Toxicology at Roche Palo Alto LLC, Director-Molecular Pharmacology at Syntex Pharmaceuticals Ltd., Director-Drug Development at Antoxis Ltd., and VP-Preclinical Sciences & Pharmaceutical Analysis at IQVIA Ltd.
Patmore received an undergraduate degree in 1976 and a doctorate degree in 1979 from the University of East Anglia.
Postes actifs de Leslie Patmore
Sociétés | Poste | Début |
---|---|---|
Aptuit Consulting, Inc. | Corporate Officer/Principal | 09/12/2009 |
Safety Pharmacology Society | Directeur/Membre du Conseil | 09/12/2009 |
Anciens postes connus de Leslie Patmore
Sociétés | Poste | Fin |
---|---|---|
Syntex Pharmaceuticals Ltd. | Corporate Officer/Principal | 01/01/1995 |
Roche Palo Alto LLC
Roche Palo Alto LLC Pharmaceuticals: MajorHealth Technology Roche Palo Alto LLC discovers and develops medicines. Its medicines are used for the treatment of central nervous system, inflammation, metabolism, oncology, and virology diseases. The company was founded in 1961 and is headquartered in Palo Alto, CA. | Corporate Officer/Principal | - |
IQVIA Ltd.
IQVIA Ltd. Information Technology ServicesTechnology Services IQVIA Ltd. provides professional services, information and partnering solutions. The firm serves its services to pharmaceutical, biotechnology, medical device and healthcare industries. It also provides contract research, sales, marketing, healthcare policy consulting and health information management services. The company was founded by Dennis Barry Gillings in 1995 and is headquartered in Reading, the United Kingdom. | Corporate Officer/Principal | - |
Antoxis Ltd.
Antoxis Ltd. BiotechnologyHealth Technology Antoxis Ltd. designs and develops synthesis therapeutic antioxidants. The firm also develops innovative approaches for the treatment of neurodegenerative conditions, cardiovascular disease, cancer and inflammatory disorders through its mitochondrial-targeted, redox technology platform. The company was founded by Andrew Scott Johnstone and Donald Barton Mcphail in March 2005 and is headquartered in Aberdeen, the United Kingdom. | Corporate Officer/Principal | - |
Formation de Leslie Patmore
University of East Anglia | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 6 |
---|---|
Antoxis Ltd.
Antoxis Ltd. BiotechnologyHealth Technology Antoxis Ltd. designs and develops synthesis therapeutic antioxidants. The firm also develops innovative approaches for the treatment of neurodegenerative conditions, cardiovascular disease, cancer and inflammatory disorders through its mitochondrial-targeted, redox technology platform. The company was founded by Andrew Scott Johnstone and Donald Barton Mcphail in March 2005 and is headquartered in Aberdeen, the United Kingdom. | Health Technology |
Roche Palo Alto LLC
Roche Palo Alto LLC Pharmaceuticals: MajorHealth Technology Roche Palo Alto LLC discovers and develops medicines. Its medicines are used for the treatment of central nervous system, inflammation, metabolism, oncology, and virology diseases. The company was founded in 1961 and is headquartered in Palo Alto, CA. | Health Technology |
Aptuit Consulting, Inc. | |
Safety Pharmacology Society | |
IQVIA Ltd.
IQVIA Ltd. Information Technology ServicesTechnology Services IQVIA Ltd. provides professional services, information and partnering solutions. The firm serves its services to pharmaceutical, biotechnology, medical device and healthcare industries. It also provides contract research, sales, marketing, healthcare policy consulting and health information management services. The company was founded by Dennis Barry Gillings in 1995 and is headquartered in Reading, the United Kingdom. | Technology Services |
Syntex Pharmaceuticals Ltd. |